NEW YORK (GenomeWeb News) – DermTech today announced that it has raised $5.6 million in a private round of financing to support future development and commercialization of its qPCR-based melanoma detection assay.

Jacobs Investment Company led the Series B financing with additional investments coming from other existing and new investors, which were not named.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.